Does Divalproex Sodium Interact with Ertapenem Sodium?
CDI records a major classification for Divalproex Sodium and Ertapenem Sodium. The stored summary is: Concomitant use results in reduction of valproic acid concentrations below therapeutic range, increasing risk of breakthrough seizures. Generally not recommended. The mechanism involves carbapenems may inhibit hydrolysis of valproic acid's glucuronide metabolite back to valproic acid. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Carbapenems may inhibit hydrolysis of valproic acid's glucuronide metabolite back to valproic acid
What To Tell Your Doctor or Pharmacist
If you are taking Divalproex Sodium and your doctor is considering prescribing Ertapenem Sodium (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider